Review
Nature Reviews Cancer 2, 897-909 (December 2002) | doi:10.1038/nrc949
Pancreatic cancer biology and genetics
Nabeel Bardeesy1 & Ronald A. DePinho1 About the authors
Abstract
Pancreatic ductal adenocarcinoma is an aggressive and devastating disease, which is characterized by invasiveness, rapid progression and profound resistance to treatment. Advances in pathological classification and cancer genetics have improved our descriptive understanding of this disease; however, important aspects of pancreatic cancer biology remain poorly understood. What is the pathogenic role of specific gene mutations? What is the cell of origin? And how does the stroma contribute to tumorigenesis? A better understanding of pancreatic cancer biology should lead the way to more effective treatments.
- View At a Glance
Author affiliations
- Department of Adult Oncology, Dana–Farber Cancer Institute and Departments of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Correspondence to: Ronald A. DePinho1 Correspondence to:Email: Ron_Depinho@dfci.harvard.edu
|
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated RESEARCH |
